Merck & Co., Inc.
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$149.52+3.19 (+2.18%)
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Non-GAAP Effective Income Tax Rate by Quarter
Non-GAAP Effective Income Tax Rate (%) (%)
Merck Non-GAAP Effective Income Tax Rate: 160.3% in Q2 2026, up 145.3 pts from a year earlier. That is the highest of the 38 quarters on record here.
Latest, Q2 2026
160.3%
Period ended Jun 30, 2026
Change on a year earlier
+145.3 pts
15.0% in Q2 2025
History
38 quarters
Since Q4 2016
Sources
32
Documents cited below
Where the Q2 2026 figure comes from
“|| Tax Rate | -95.9 | % | 160.3 | %”
Source: Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Reported in Form 8-K Table 2a.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Merck Non-GAAP Effective Income Tax Rate (%), quarterly Q4 2016–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/nongaap-etr
See every metric in the Merck KPI table. Data updated Oct 26, 2026.